ADPT Research and Charts

ADPT - Adaptive Biotechnologies Corp (Healthcare: Biotechnology)

Projected Earnings Date: 2025-02-06 (Delayed quote data 2025-01-03)

Last 7.20	Change ⇑ +1.01 (+16.32%)	Volume 1,080,562
	Open 6.31	High 7.22	Low 6.31

8EMA (Daily) 6.43	40EMA (Daily) 5.96	50EMA (Daily) 5.83	STO (Daily) 42.276	MACD Hist (Daily) 0.025
8EMA (Weekly) 6.194	40EMA (Weekly) 5.04	50EMA (Weekly) 5.06	STO (Weekly) 82.269	MACD Hist (Weekly) 0.362


Company Profile
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.